Target intelligence / Profile preview

Colonic mucosa and intestinal lumen

Molecular classification
Other
01

Overview

The colonic mucosa and intestinal lumen represent the anatomical and physiological environment of the large intestine, serving as a critical interface between the host and the external environment, including the gut microbiome (NIH, 2023). The mucosa consists of an epithelial layer, lamina propria, and muscularis mucosae, providing a selective barrier that facilitates water and electrolyte absorption while preventing the entry of pathogens (StatPearls, 2023). The intestinal lumen is the interior space where waste is processed and microbial fermentation occurs. While not a single molecular target, this site is the focus of numerous locally acting therapies for conditions such as inflammatory bowel disease (IBD) and functional gastrointestinal disorders (PubMed, 2022). Drugs interacting with this environment may employ non-specific mechanisms, such as osmotic activity or physical adsorption, or target specific receptors and enzymes localized within the mucosal tissue. This designation is often used in pharmacological databases to categorize drugs that exert their primary effect within the gut without a single defined protein target.

Other names
Intestinal liningGut lumenColonic epitheliumGastrointestinal environmentLarge intestinal mucosa
02

Mechanism of action

Drugs targeting this site typically act through local mechanisms such as the modulation of mucosal inflammation, alteration of luminal osmotic pressure, physical adsorption of toxins, or activation of ion channels (e.g., CFTR or ClC-2) on the apical surface of enterocytes to promote fluid secretion.

03

Biological functions

AbsorptionSecretionBarrier functionImmune regulationMicrobiome habitatWater reabsorption
04

Disease associations

Inflammatory bowel diseaseIrritable bowel syndromeColorectal cancerInfectionConstipationDiarrhea
05

Safety considerations

Systemic absorption of locally acting agentsElectrolyte imbalanceDisruption of the commensal microbiomeMucosal irritation or erosionMalabsorption of nutrients
06

Interacting drugs

Mesalamine

7 more in the full profile.

07

Biomarkers

Fecal calprotectinFecal immunochemical test (FIT)C-reactive protein (CRP)Endoscopic mucosal healing score

Beyond the preview

Go deeper on Colonic mucosa and intestinal lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic mucosa and intestinal lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call